# Shanghai Pulmonary Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/shanghai-pulmonary-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 27.5 |
| Citations | 759,341 |
| City | Shanghai |
| Country | CN |
| Description | Shanghai Pulmonary Hospital is a research organisation in Shanghai, CN. OpenAlex records 8,293 works and 759,341 citations for it. 2,742 researchers list it as their most recent affiliation. |
| Homepage | http://med.tongji.edu.cn/english/article.asp?article_id=6219&category_id=2098&root_id=2086 |
| OpenAlex ID | https://openalex.org/I4210127126 |
| Researchers | 2,742 |
| ROR ID | https://ror.org/033nbnf69 |
| Type | healthcare |
| Works | 8,293 |

## University papers

Showing 12 of 22.

- [Role of IL-2 in cancer immunotherapy](https://scholariq.org/papers/role-of-il-2-in-cancer-immunotherapy/)
- [Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients](https://scholariq.org/papers/investigating-novel-resistance-mechanisms-to-third-generation-egfr-tyrosine/)
- [TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway](https://scholariq.org/papers/timp1-is-a-prognostic-marker-for-the-progression-and-metastasis-of-colon-cancer/)
- [Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer](https://scholariq.org/papers/low-dose-apatinib-optimizes-tumor-microenvironment-and-potentiates-antitumor/)
- [Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial](https://scholariq.org/papers/camrelizumab-plus-carboplatin-and-paclitaxel-as-first-line-treatment-for/)
- [Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer](https://scholariq.org/papers/combined-radiotherapy-and-anti-pd-l1-antibody-synergistically-enhances-antitumor/)
- [HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib](https://scholariq.org/papers/her2-exon-20-insertions-in-non-small-cell-lung-cancer-are-sensitive-to-the/)
- [Early detection of lung cancer by using an autoantibody panel in Chinese population](https://scholariq.org/papers/early-detection-of-lung-cancer-by-using-an-autoantibody-panel-in-chinese/)
- [Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs](https://scholariq.org/papers/consolidative-local-ablative-therapy-improves-the-survival-of-patients-with/)
- [Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?](https://scholariq.org/papers/immune-checkpoint-inhibitors-in-egfr-mutated-nsclc-dusk-or-dawn/)
- [Interaction between CAF and CD8+ T cells in non-small cell lung cancer affects prognosis and efficacy of immunotherapy.](https://scholariq.org/papers/interaction-between-caf-and-cd8-t-cells-in-non-small-cell-lung-cancer-affects/)
- [CD8+ T cell/cancer-associated fibroblast ratio stratifies prognostic and predictive responses to immunotherapy across multiple cancer types](https://scholariq.org/papers/cd8-t-cell-cancer-associated-fibroblast-ratio-stratifies-prognostic-and/)

## University researchers

- [Tao Jiang](https://scholariq.org/researchers/tao-jiang/)
- [Xinlong Zheng](https://scholariq.org/researchers/xinlong-zheng/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Tuberculosis Research and Epidemiology](https://scholariq.org/topics/tuberculosis-research-and-epidemiology/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.